{"id":32716,"date":"2016-12-15T21:03:33","date_gmt":"2016-12-16T05:03:33","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/12\/ttfields-prolong-overall-survival-in-glioblastoma"},"modified":"2017-06-04T13:57:43","modified_gmt":"2017-06-04T20:57:43","slug":"ttfields-prolong-overall-survival-in-glioblastoma","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/12\/ttfields-prolong-overall-survival-in-glioblastoma","title":{"rendered":"TTFields Prolong Overall Survival in Glioblastoma"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/ttfields-prolong-overall-survival-in-glioblastoma.jpg\"><\/a><\/p>\n<p>Very promising for Giloblastoma patients.<\/p>\n<hr>\n<p>Adding Tumor Treating Fields (TTFields) to maintenance temozolomide significantly prolongs both median and long-term survival.<\/p>\n<p>Among patients with newly diagnosed <a href=\"http:\/\/www.cancertherapyadvisor.com\/brain-cancer\/section\/1348\/\" target=\"_self\">glioblastoma multiforme<\/a>, adding Tumor Treating Fields (TTFields) to maintenance temozolomide significantly prolongs both median and long-term survival, according to a study presented 21st Annual Scientific Meeting of the Society of Neuro-Oncology (SNO).<\/p>\n<p>TTFields is a frequency-tuned, anti-mitotic, physical treatment modality delivered to the brain through a patient-operated, portable medical device called Optune. Results of a pre-specific successful interim analysis of the international, phase 3 trial (ClinicalTrials.gov Identifier: <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00916409\">NCT00916409<\/a>) comparing TTFields and temozolomide with temozolomide alone after radiotherapy and adjuvant temozolomide led to the approval of TTFields for the treatment of adult patients with glioblastoma.<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.cancertherapyadvisor.com\/brain-cancer\/glioblastoma-treatment-tumor-fields-ttfields-prolongs-survival\/article\/579570\/\">http:\/\/www.cancertherapyadvisor.com\/brain-cancer\/glioblastom...le\/579570\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Very promising for Giloblastoma patients. Adding Tumor Treating Fields (TTFields) to maintenance temozolomide significantly prolongs both median and long-term survival. Among patients with newly diagnosed glioblastoma multiforme, adding Tumor Treating Fields (TTFields) to maintenance temozolomide significantly prolongs both median and long-term survival, according to a study presented 21st Annual Scientific Meeting of the Society of [\u2026]<\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-32716","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=32716"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32716\/revisions"}],"predecessor-version":[{"id":65572,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32716\/revisions\/65572"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=32716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=32716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=32716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}